Old Mission Capital »

Innate Pharma shares owned by Old Mission Capital

Quarter-by-quarter ownership of Innate Pharma (IPHA) shares owned by Old Mission Capital from 13F filings

Historical chart of Old Mission Capital investment in Innate Pharma

Tip: Access up to 7 years of quarterly data

All positions including Innate Pharma held by Old Mission Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Innate Pharma by Old Mission Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $50k 28k 1.75
2019-12-31 $84k 13k 6.44

More positions owned by Old Mission Capital

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Strategy Cl A New (MSTR)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Coinbase Global Com Cl A (COIN)
Ishares Tr Msci Eafe Etf Call Option (EFA)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Vaneck Etf Trust Semiconductr Etf (SMH)
Vanguard Intl Equity Index F Ftse Pacific Etf (VPL)
Ishares Tr Msci China Etf (MCHI)

View all positions for Old Mission Capital

Top funds holding Innate Pharma

Jane Street
Lion Point Capital
Old Mission Capital
Citadel Advisors
Rhumbline Advisers
GAMMA Investing
UBS Group
Farther Finance Advisors
SageView Advisory Group
Barclays

View all funds holding Innate Pharma